While the company reports its initiatives are starting to pay off, its Q3 filings show several areas of financial strain.

Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

The Wilmington-based contract research organization offered new details in its third-quarter earnings about its ongoing restructuring initiatives, including the extent of layoffs and site ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

In a report released on November 7, Patrick B Donnelly from Citi maintained a Sell rating on Charles River Labs (CRL – Research Report).

Charles River Labs provides products and services to pharma and biotech companies to help accelerate research and drug ...

WILMINGTON, Mass. — WILMINGTON, Mass. — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the Wilmington, ...

TD Cowen raised the firm’s price target on Charles River (CRL) to $227 from $203 and keeps a Hold rating on the shares. The firm said solid 3Q results are positive indication thhe company is nearing a ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the ...

Inside a large but nondescript building near the Longfellow Bridge on the Cambridge side of the Charles River is what’s essentially a jet engine. “If you look up, you’ll get a sense of the size,” said ...

The Charles River is ready for the rowers. Starting today, more than 12,000 athletes and tens of thousands of fans will head to Greater Boston’s iconic river for the three-day Head of the ...